BRPI1010516A2 - Métodos de tratamento de edema relacionados à isquemia-reperfusão - Google Patents

Métodos de tratamento de edema relacionados à isquemia-reperfusão

Info

Publication number
BRPI1010516A2
BRPI1010516A2 BRPI1010516-6A BRPI1010516A BRPI1010516A2 BR PI1010516 A2 BRPI1010516 A2 BR PI1010516A2 BR PI1010516 A BRPI1010516 A BR PI1010516A BR PI1010516 A2 BRPI1010516 A2 BR PI1010516A2
Authority
BR
Brazil
Prior art keywords
reperfusion
ischemia
treatment methods
related edema
edema treatment
Prior art date
Application number
BRPI1010516-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Thomas Michael Egan
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Publication of BRPI1010516A2 publication Critical patent/BRPI1010516A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • A01N1/126Physiologically active agents, e.g. antioxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI1010516-6A 2009-04-09 2010-04-09 Métodos de tratamento de edema relacionados à isquemia-reperfusão BRPI1010516A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16808909P 2009-04-09 2009-04-09
PCT/US2010/030556 WO2010118334A1 (en) 2009-04-09 2010-04-09 Methods of treating edema related to ischemia-reperfusion

Publications (1)

Publication Number Publication Date
BRPI1010516A2 true BRPI1010516A2 (pt) 2015-08-25

Family

ID=42936599

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010516-6A BRPI1010516A2 (pt) 2009-04-09 2010-04-09 Métodos de tratamento de edema relacionados à isquemia-reperfusão

Country Status (14)

Country Link
US (1) US20120064044A1 (enExample)
EP (1) EP2416651A4 (enExample)
JP (1) JP2012523432A (enExample)
KR (1) KR20120005025A (enExample)
CN (1) CN102458113A (enExample)
AU (1) AU2010233151A1 (enExample)
BR (1) BRPI1010516A2 (enExample)
CA (1) CA2757998A1 (enExample)
EA (1) EA201101349A1 (enExample)
IL (1) IL215604A0 (enExample)
MX (1) MX2011010616A (enExample)
SG (1) SG175133A1 (enExample)
WO (1) WO2010118334A1 (enExample)
ZA (1) ZA201107815B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009126822A2 (en) * 2008-04-09 2009-10-15 The University Of North Carolina At Chapel Hill Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
US9205100B2 (en) 2011-03-03 2015-12-08 Quark Pharmaceuticals, Inc. Compositions and methods for treating lung disease and injury
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
US11903963B2 (en) 2017-03-10 2024-02-20 The University Of North Carolina At Chapel Hill Short-acting heparin-based anticoagulant compounds and methods
US11993627B2 (en) 2017-07-03 2024-05-28 The University Of North Carolina At Chapel Hill Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides
EP3691653B1 (en) 2017-11-03 2025-03-12 The University Of North Carolina At Chapel Hill Sulfated oligosaccharides having anti-inflammatory activity
CA3090271A1 (en) 2018-02-12 2019-08-15 Inimmune Corporation Toll-like receptor ligands
WO2019246264A1 (en) 2018-06-20 2019-12-26 The University Of North Carolina At Chapel Hill Cell protective methods and compositions
EP4041251A4 (en) * 2019-11-13 2023-11-29 The University of North Carolina at Chapel Hill Heparan sulfate (hs) oligosaccharides effect in liver ischemia reperfusion injury

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05139992A (ja) * 1991-11-13 1993-06-08 Ajinomoto Co Inc ヒトadfを含有する臓器保護剤
US6113918A (en) * 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US7960522B2 (en) * 2003-01-06 2011-06-14 Corixa Corporation Certain aminoalkyl glucosaminide phosphate compounds and their use
JPWO2004085396A1 (ja) * 2003-03-26 2006-06-29 三菱ウェルファーマ株式会社 虚血再灌流障害の予防または治療剤、臓器保存剤およびスクリーニング方法
US7928132B2 (en) * 2004-08-06 2011-04-19 Ohio University Methods for the amelioration of episodes of acute or chronic ulcerative colitis
US20060211752A1 (en) * 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
AU2008285626B2 (en) * 2007-08-03 2013-09-12 Neuramedy Co., Ltd. Use of TLR-2 antagonists for treatment of reperfusion injury and tissue damage
WO2009126822A2 (en) * 2008-04-09 2009-10-15 The University Of North Carolina At Chapel Hill Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation

Also Published As

Publication number Publication date
WO2010118334A1 (en) 2010-10-14
CN102458113A (zh) 2012-05-16
ZA201107815B (en) 2013-04-24
EP2416651A1 (en) 2012-02-15
IL215604A0 (en) 2011-12-29
JP2012523432A (ja) 2012-10-04
AU2010233151A1 (en) 2011-11-17
SG175133A1 (en) 2011-12-29
MX2011010616A (es) 2012-03-14
KR20120005025A (ko) 2012-01-13
EP2416651A4 (en) 2014-03-26
CA2757998A1 (en) 2010-10-14
US20120064044A1 (en) 2012-03-15
EA201101349A1 (ru) 2012-05-30

Similar Documents

Publication Publication Date Title
BRPI0910854A2 (pt) métodos de tratamento
BR112012005594A2 (pt) tratamento de câncer
BRPI0910259A2 (pt) métodos de tratamento de inflamação
DK2330887T3 (da) Behandlingsindretning
EP2488689A4 (en) LAUNDRY TREATMENT APPARATUS
EP3957283C0 (en) TREATMENT OF OBESITY
BRPI0914841A2 (pt) aparelho de massagem
ATE526024T1 (de) Fluvoxamin vermeidende pirfenidontheraphy
LT2405869T (lt) Nutukimo gydymas
EP2435825A4 (en) METHODS OF TREATING DISEASES
DK2173831T3 (da) Brøndbehandling
BR112013022820A2 (pt) método de tratamento
BRPI1010516A2 (pt) Métodos de tratamento de edema relacionados à isquemia-reperfusão
EP3381471C0 (en) PAIN TREATMENT
EP2415408A4 (en) Treatment device
BRPI1007543A2 (pt) tratamento de psoríase
HRP20160577T1 (hr) Liječenje osteoartritisa
BR112012004071A2 (pt) tratamento de petróleo
BRPI1013903A2 (pt) tratamentos terapêuticos utilizando centaquina
DK2437839T3 (da) Lysbehandlingsindretning
BRPI0922216A2 (pt) tratamento para glomerulonefrite
EP2266520A4 (en) Massage machine
BR112012010525A2 (pt) novos processos
IT1403226B1 (it) Trattamento impermeabilizzante
FI9141U1 (fi) Apuväline

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.